Pamela Harding, PhD

Biographical Statement

Dr. Pamela Harding is a senior scientist in the Hypertension and Vascular Research Division at Henry Ford Health, an adjunct research professor in the Department of Pharmacology and Toxicology at Michigan State University (MSU) and an adjunct associate professor in the Department of Physiology at Wayne State University School of Medicine. An accomplished cardiovascular researcher, Dr. Harding has dedicated her career to advancing the understanding of the molecular mechanisms that regulate heart function, with a particular focus on the role of prostaglandin E2 and its receptors in cardiovascular health and disease.

Dr. Harding earned her doctorate from Keele University in the United Kingdom and subsequently completed postdoctoral training in the Hypertension and Vascular Research Division at Henry Ford Hospital. She further advanced her research training in the Department of Pathology at Eastern Virginia Medical School, where she began her independent investigative career before returning to Henry Ford Health to expand her research program.

Throughout her career, Dr. Harding has led federally funded research focused on cardiovascular physiology, hypertension and kidney disease. She has served on review panels for both the National Institutes of Health and the American Heart Association and has received continuous support from these organizations for her scientific work. Her research has contributed to a deeper understanding of the pathways that influence cardiovascular function and has helped identify potential therapeutic targets for heart failure, hypertension and related diseases.

Research Interests

• Prostaglandin signaling in cardiovascular pathophysiology
• Hypertension and blood pressure regulation
• Role of inflammation and metabolism in heart failure
• Molecular mechanisms of heart and kidney disease

Email: PHARDIN1@hfhs.org